pirfenidone has been researched along with Carcinoma, Non-Small Cell Lung in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 6 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antunes, C; Branco, H; Oliveira, J; Santos, LL; Vasconcelos, MH; Xavier, CPR | 1 |
| Cao, L; Deng, P; Hu, C; Li, Y; Liu, J; Pan, P; Yang, H | 1 |
| Didiasova, M; Drakopanagiotakis, F; Krämer, M; Mamazhakypov, A; Markart, P; Schaefer, L; Wygrecka, M | 1 |
| Fujiwara, A; Fukui, E; Funaki, S; Kanou, T; Kimura, K; Minami, M; Ose, N; Shintani, Y | 1 |
| Akazawa, Y; Ishijima, M; Kanazu, M; Kuge, T; Mori, M; Okabe, F; Uenami, T; Yamaguchi, T; Yamamoto, Y; Yano, Y | 1 |
| Miao, K; Tian, X; Xu, W; Xu, Y; Zhang, L; Zhang, Y | 1 |
| Ballester, B; Cortijo, J; Milara, J | 1 |
| Fujiwara, A; Funaki, S; Kawamura, T; Kimura, T; Minami, M; Okumura, M; Shintani, Y | 1 |
1 review(s) available for pirfenidone and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Idiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular Targets.
Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Humans; Idiopathic Pulmonary Fibrosis; Indoles; Lung Neoplasms; Myofibroblasts; Pyridones | 2019 |
7 other study(ies) available for pirfenidone and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Pirfenidone Sensitizes NCI-H460 Non-Small Cell Lung Cancer Cells to Paclitaxel and to a Combination of Paclitaxel with Carboplatin.
Topics: Antineoplastic Agents; Apoptosis; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Humans; Lung Neoplasms; Paclitaxel; Pyridones | 2022 |
Pirfenidone promotes the levels of exosomal miR-200 to down-regulate ZEB1 and represses the epithelial-mesenchymal transition of non-small cell lung cancer cells.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; MicroRNAs; Neoplasm Invasiveness; Pyridones; Tumor Microenvironment; Zinc Finger E-box-Binding Homeobox 1 | 2022 |
Pirfenidone inhibits motility of NSCLC cells by interfering with the urokinase system.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Indoleacetic Acids; Lung Neoplasms; Membrane Proteins; Plasminogen Activator Inhibitor 1; Pyridones; Tumor Microenvironment; Urokinase-Type Plasminogen Activator | 2020 |
Effects of pirfenidone targeting the tumor microenvironment and tumor-stroma interaction as a novel treatment for non-small cell lung cancer.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Differentiation; Cell Line, Tumor; Culture Media, Conditioned; Fibroblasts; Humans; Lung Neoplasms; Mice; Mice, Nude; Myofibroblasts; Pyridones; Stromal Cells; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2020 |
Safety and effectiveness of pirfenidone combined with carboplatin-based chemotherapy in patients with idiopathic pulmonary fibrosis and non-small cell lung cancer: A retrospective cohort study.
Topics: Aged; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Female; Humans; Idiopathic Pulmonary Fibrosis; Immune Checkpoint Inhibitors; Lung Neoplasms; Male; Middle Aged; Pyridones; Retrospective Studies | 2020 |
Treatment of steroid-resistant checkpoint inhibitor pneumonitis with pirfenidone: A case report.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Immunological; Carcinoma, Non-Small-Cell Lung; Drug-Related Side Effects and Adverse Reactions; Humans; Lung Neoplasms; Male; Pneumonia; Pyridones | 2021 |
Pirfenidone plays a biphasic role in inhibition of epithelial-mesenchymal transition in non-small cell lung cancer.
Topics: Animals; Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Epithelial-Mesenchymal Transition; Female; Fibroblasts; Humans; Lung Neoplasms; Mice; Phosphorylation; Pyridones; Signal Transduction; Smad2 Protein; Transforming Growth Factor beta1 | 2017 |